October 27, 2020 FDA Awards C-Path Grant to Use Real-World Data to Generate Real-World Evidence in Neonates Pilot project will include the development of a Real-World Data and Analytics Platform TUCSON, Ariz., October 27, 2020 — Arizona
October 20, 2020 Rare Disease Cures Accelerator-Data and Analytics Platform First Year Milestones Highlighted at Virtual Workshop C-Path, NORD, FDA and more come together to showcase the importance of data sharing in rare disease drug development
October 19, 2020 Watch Now: RDCA-DAP 2020 Virtual Workshop Join us for the Rare Disease Cures Accelerator-Data and Analytics Platform (RDCA-DAP) annual workshop and learn more about: RDCA-D
October 10, 2020 Watch Now: Accelerating Drug Development for Rare Diseases through Data Sharing and Analysis Webinar Despite increasing numbers of drug targets and technologies, rare disease drug development is frequently slowed by t
October 9, 2020 Webinar: Accelerating Drug Development for Rare Diseases through Data Sharing and Analysis (Sept.18, 2020)
October 9, 2020 How Math, Statistics, and Artificial Intelligence Can be Used to Develop Treatments for Major Diseases: Quantitative Medicine at the Critical Path Institute
September 17, 2020 C-Path Launches Consortium to Accelerate Medical Product Development in Sickle Cell Disease September is National Sickle Cell Awareness Month TUCSON, Ariz., Sept. 17, 2020 — The Critical Path Institute (C-Path) today
